Recruiting Lupus Nephritis Studies in Boston
Confirmation of Diet as a Treatment for Gulf War Illness
This clinical trial aims to confirm previous findings from a smaller study which demonstrated significant improvements in all symptoms among veterans with Gulf War Illness after one month on the dieta...
A Study of Rapcabtagene Autoleucel in Systemic Lupus Erythematosus (SLE) Patients With Active, Refractory Lupus Nephritis (LN)
The purpose of this study is to evaluate the efficacy and safety of rapcabtagene autoleucel (administered once following lymphodepletion) versus Standard of Care (SOC) in patients with systemic lupus ...
About Lupus Nephritis Clinical Trials in Boston
Lupus nephritis is kidney inflammation caused by systemic lupus erythematosus, occurring in up to 60% of SLE patients. It can lead to kidney failure if untreated. Treatment includes immunosuppressive medications such as mycophenolate, cyclophosphamide, and newer agents like voclosporin.
There are currently 2 lupus nephritis clinical trials recruiting participants in Boston, MASSACHUSETTS. These studies are seeking a combined 304 participants. Research is being sponsored by American University, Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lupus Nephritis Clinical Trials in Boston — FAQ
Are there lupus nephritis clinical trials in Boston?
Yes, there are 2 lupus nephritis clinical trials currently recruiting in Boston, MASSACHUSETTS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Boston?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.
Are clinical trials in Boston free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.
What lupus nephritis treatments are being tested?
The 2 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for lupus nephritis.
Data updated March 2, 2026 from ClinicalTrials.gov